Pneumocystis Carinii Pneumonia in Adolescents
Bret J.Rudy, R.M.R.,S.A.N.
Pediatric Drugs 2(2): 133-138
2000
ISSN/ISBN: 1174-5878
DOI: 10.2165/00148581-200002020-00006
Accession: 068042510
PDF emailed within 0-6 h: $19.90
Related References
Wessel, K.; Szelenyi, I. 1992: Selegiline An overview of its role in the treatment of Parkinson's disease Journal of Molecular Medicine 70(5): 459-462Postma, A.; Kamps, W.A. 1998: Prevention ofPneumocystis cariniipneumonia with cotrimoxazole 18 mg/kg Supportive Care in Cancer 6(3): 300-300
Akbar, H.; Pinçon, C.; Aliouat-Denis, C.-M.; Derouiche, S.; Taylor, M.-L.; Pottier, M.; Carreto-Binaghi, L.-H.; González-González, A.E.; Courpon, A.; Barriel, V.ér.; Guillot, J.; Chabé, M.; Suarez-Alvarez, R.O.; Aliouat, E.M.; Dei-Cas, E.; Demanche, C. 2012: Characterizing Pneumocystis in the lungs of bats: understanding Pneumocystis evolution and the spread of Pneumocystis organisms in mammal populations Applied and Environmental Microbiology 78(22): 8122-8136
Damiani, C.él.; Le Gal, S.èn.; Da Costa, C.éc.; Virmaux, M.èl.; Nevez, G.; Totet, A. 2013: Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization Journal of Clinical Microbiology 51(10): 3380-3388
Tesini, B.L.; Wright, T.W.; Malone, J.E.; Haidaris, C.G.; Harber, M.; Sant, A.J.; Nayak, J.L.; Gigliotti, F. 2017: Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii Infection and Immunity 85(4)
Dr Keikawus, N. Arastéh,Hans, F. Vöhringer,Walter, S. Heise… 1994: Pentamidine Aerosolvs Cotrimoxazole in the Treatment of Slight to Moderate Pneumocystis carinii Pneumonia Clinical Drug Investigation 8(6): 321-330
Rudy, B.J.; Rutstein, R.M.; Nachman, S.A. 2000: Pneumocystis carinii pneumonia in adolescents Paediatric Drugs 2(2): 133-138
Koppen, S.; Grunewald, T.; Jautzke, G.; Ruf, B. 1991: Upper lobe relapse ofPneumocystis carinii Pneumonia during aerosolized pentamidine prophylaxis Journal of Molecular Medicine 69(10): 446-448
Durant, J.; Hazime, F.; Carles, M.; Pechere, J.C.; Dellamonica, P. 1995: Prevention ofPneumocystis cariniipneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients Infection 23(1 Suppl): S33-S38
Roos, M. Perenboom; Wim, J. G. Oyen; Anita, C. H. W. Schijndel; Pieter Beckers; Frans, H. M. Corstens; Jos, W. M. Meer 1995: Serial indium-111-labelled IgG biodistribution in rat Pneumocystis cariniipneumonia: a tool to monitor the course and severity of the infection European Journal of Nuclear Medicine and Molecular Imaging 22(10): 1129-1132
Dr Keikawus, N. Arastéh,Hans, F. Vöhringer,Michael, M. Stratmann… 1993: Pharmacokinetics and Adverse Reactions of Various Dosage Regimens of Intravenous Pentamidine in the Treatment of HIV-Associated Pneumocystis carinii Pneumonia Clinical Drug Investigation 6(4): 207-217
Anonymous 1992: Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV JAMA, Journal of the American Medical Association 267(17): 2294-2296, 2298-2299
Groll, A.H.; Ritter, J.; Müller, F.M. 2001: Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer Klinische Padiatrie 213 Suppl. 1: A38-A49
Hiroshi Miyawaki; Jiro Fujita; Ichiro Yamadori; Satoko Hojo; Yuka Obayashi; Hiroyuki Nakamura; Yasufumi Yamaji; Ichizo Suemitsu; Masakazu Harada; Setsuo Suguri; Jiro Takahara 1998: Detection ofPneumocystis cariniisequences in serum by polymerase chain reaction: Clinical application in two patients withP. cariniipneumonia Journal of Infection and ChemoTherapy 4(1): 36-39
De Armas, Y.; Capó, V.; Pérez, J.E.; Plascencia, A.; Calderón, E. 2016: Apparent Absence of Pneumocystis Jirovecii Colonization in Cuban HIV-infected Children and Adolescents Pediatric Infectious Disease Journal 35(5): 594-595